Peimine Suppresses Collagen-Induced Arthritis, Activated Fibroblast-Like Synoviocytes and TNFα-induced MAPK Pathways.

Junnan Zhou,Yuhang Mao,Xiaotian Shi,Yudie Zhang,Xiaolu Yu,Xuan Liu,Li Diao,Xue Yang,Changze Liu,Dan Liu,Xin Tan,Mei Liu
DOI: https://doi.org/10.1016/j.intimp.2022.109181
IF: 5.714
2022-01-01
International Immunopharmacology
Abstract:BACKGROUND AND PURPOSE:Peimine (PM), a main isosterol alkaloid component isolated from the bulbs of traditional Chinese herb Fritillaria cirrhosa D. Don, has been demonstrated to exhibit multiple pharmacological properties, including anti-inflammation, anti-cancer and pain suppression. However, its effect on rheumatoid arthritis (RA) remains unknown. In the present study, we investigated the effect of PM on collagen-induced arthritis (CIA) rats in vivo and its inhibition on destructive behaviors of arthritic fibroblast-like synoviocytes (FLSs) in vitro.METHODS:Arthritis was induced in rats by chicken type II collagen. Arthritis score, radiological evaluation, and histopathological assessment were used to evaluate the therapeutic effects of PM on CIA rats. EdU assay, wound healing assay and real-time PCR were used to examine the inhibitory effect of PM on proliferation, migration, and over-expression of pro-inflammatory cytokines in TNFα-induced arthritic FLSs. TRAP staining and scanning electron microscopy were used to analyze the effect of PM on osteoclastogensis and bone resorption. Western blot was used to reveal PM's molecular mechanism of action on RA.RESULTS:PM significantly suppressed synovitis and bone destruction in CIA rats. In vitro experiments showed that PM treatment significantly inhibited TNFα-induced destructive behaviors of arthritic FLSs, including over-proliferation, migration and over-expression of pro-inflammatory cytokines. Additionally, RANKL-induced osteoclast formation and bone-resorpting function were also inhibited by PM. Further molecular mechanism studies revealed that PM treatment significantly suppressed TNFα-induced activations of MAPKs (ERK, JNK and p38) in arthritic FLSs.CONCLUSION:Our findings provide strong evidence that PM has the potential to be developed as a therapeutic agent for patients with RA.
What problem does this paper attempt to address?